Cite Filings / IRD / 0001140361-26-010757
Feed Companies Filings Check
Sign in
DEF 14A

Proxy Statement

Opus Genetics, Inc. · Filed 2026-03-23 · Acc 0001140361-26-010757

Documents 1

  • DEF 14A Proxy Statement , ny20063680x2_def14a.htm

Around this filing

  • 2026-03-23 ARS Annual Report to Security Holders
  • 2026-03-23 DEF 14A Proxy Statement
  • 2026-03-18 4 Chief Operating Officer sold 3,719 shares at $5.25 ($19,525)
  • 2026-03-18 4 Head of Fin. Quality Assurance sold 2,816 shares at $5.25 ($14,770)
  • 2026-03-18 4 Chief Executive Officer sold 24,438 shares at $5.21 ($127,327)
  • 2026-03-18 4 Chief Scientific & Dev. Ofc. sold 3,719 shares at $5.12 ($19,046)
  • 2024-04-29 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ny20063680x2_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…